21 May 2009
Expanded criteria living kidney donors – a single centre experience
P Domagała, R Kieszek, M Bieniasz, A Kwiatkowski, J Gozdowska, J Trzebicki, M Wszoła, M Durlik, L Pączek, A ChmuraAnn Transplant 2009; 14(1): 55-55 :: ID: 880400
Abstract
Background: Using living kidney donor's (LKD) organs is one of the strategies for making more transplants available. Results of kidney transplantation are superior when the kidney is obtained from a living donor. It is worthwhile to explain whether expanded criteria living donor kidney's acceptance is safe and offers satisfactory recipient's outcome. Aim: The aim of this study was to analyse living kidney donors and to propose the definition of expanded criteria living kidney donor.
Material/Methods: Eighty four live donor nephrectomies were performed
between 2000 and 2007. Mean donor age was 41.3 years. The donors were
predominantly female (59.2%). Open nephrectomy was performed in all
cases, usually left-sided (71.4%). In 36 (42.8%) cases the harvested kidney
was transplanted to a child. We analysed retrospectively the accessible data
of seventy six donors.
Results: We proposed risk factors that may affect both donor and recipient of the kidney. For each factor a specifi c number of points was assigned. Accordingly, a scale is suggested which defines expanded criteria living kidney donors. Kidney donors were divided into two groups-optimal donors (0-5 points) and expanded criteria donors (more than 5 points). Seven cases (9.2%) of expanded criteria living kidney donors were observed according to the proposed definition.
Conclusions: A comprehensive system of living kidney donors evaluation as
well as an assessment of influence of expanded living kidney donor factors
on short- and long-term donor outcome and recipient and graft survival are
necessary and shall be conducted in the future.
Keywords: Living Donors
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






